Melbourne Locoregional Melanoma 2016 conference 26-27 August

July 26, 2016

Friday 26 August 2016

This day will include an introduction to melanoma immunology and immunotherapy. Tumour biology will be investigated, and there will be thorough discussions on checkpoint inhibitors, injectable therapies and cellular therapies. Day one will also include the ANZMTG Annual Meeting, with presentations and discussion of new project proposals.

Saturday 27 August 2016

This day will focus on the clinical management of the complex patient group with locoregionally advanced melanoma. National and international experts will explore various clinical aspects of management including surgery, regional therapies and systemic treatment options.

International speakers:

Dr James P Allison, PhD
Professor and Chair - Department of Immunology; Director - Immunology Platform, and Deputy Director - David H. Koch Center for Applied Research in Genitourinary Cancers, Department of Genitourinary Research, University of Texas MD Anderson Cancer Center, Houston, Texas

Assoc Prof Robert Andtbacka, MD, CM, FACS
Associate Professor of Surgery - Surgical Oncology, Department of Surgery, University of Utah, Huntsman Cancer Institute, Utah, USA

Dr Carolyn Nessim, MD, MSc, FRCSC
Surgical Oncologist - Ottawa Hospital, Canada

Dr Michael A Postow, MD
Medical Oncologist - Melanoma and Immunotherapeutics Service at Memorial Sloan Kettering Cancer Center, New York

Further details and registration: http://lrmelanoma2016.com.au/home or email anzmtg@melanoma.org.au

See also:

Melanoma Information Forum, hosted by Melanoma Patients Australia: Friday 26 August 4:00 – 6.30 pm
Further details:  http://lrmelanoma2016.com.au/scientific-program/consumer-forum